Arcus Biosciences, Inc. Nonoperating Income (Expense) in USD from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Arcus Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to Q3 2025.
  • Arcus Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $7M, a 46.2% decline year-over-year.
  • Arcus Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $35M, a 28.6% decline year-over-year.
  • Arcus Biosciences, Inc. annual Nonoperating Income (Expense) for 2024 was $48M, a 23.1% increase from 2023.
  • Arcus Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $39M, a 179% increase from 2022.
  • Arcus Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $14M, a 1300% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

Arcus Biosciences, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $35M $7M -$6M -46.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 $41M $8M -$5M -38.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $46M $10M -$2M -16.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $48M $10M -$1M -9.09% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $49M $13M +$2M +18.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 $47M $13M +$4M +44.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $43M $12M +$4M +50% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $39M $11M +$4.19M +61.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $34.8M $11M +$6M +120% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $28.8M $9M +$7M +350% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $21.8M $8M +$7.81M +4088% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $14M $6.81M +$6.29M +1212% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 $7.71M $5M +$4.84M +3006% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.87M $2M +$1.83M +1105% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.04M $191K +$37K +24% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1M $519K +$737K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $263K $161K -$109K -40.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $372K $166K -$135K -44.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $507K $154K -$493K -76.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1M -$218K -$1.15M -123% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $2.15M $270K -$627K -69.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.77M $301K -$769K -71.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $3.54M $647K -$456K -41.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $4M $929K -$260K -21.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $4.26M $897K -$436K -32.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $4.7M $1.07M -$1.3M -54.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $5.99M $1.1M +$726K +193% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $5.27M $1.19M +$1.06M +794% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $4.21M $1.33M +$1.32M +11008% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $2.89M $2.37M +$2.25M +1975% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $636K $377K +$277K +277% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $359K $133K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 $12K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $114K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $100K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09

Arcus Biosciences, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $48M +$9M +23.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $39M +$25M +179% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $14M +$13M +1300% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $1M $0 0% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $1M -$3M -75% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $4M -$1.27M -24% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $5.27M +$4.91M +1367% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $359K +$147K +69.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-05
2016 $212K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.